Matteo Manfredi
Papers
1
Total Citations
8
H-Index
1
About
Matteo Manfredi is a urological surgeon and researcher at the forefront of integrating cutting-edge technology into minimally invasive surgical practice. His work sits at the compelling intersection of robotic surgery, artificial intelligence, and augmented reality, with a particular focus on improving oncological outcomes in prostate cancer treatment. Manfredi's most prominent contribution to date is his leadership of the RIDERS Trial, a prospective randomized study comparing AI-driven 3D augmented reality–guided robotic prostatectomy against conventional cognitive MRI-guided intervention — a landmark investigation that represents one of the first rigorous head-to-head evaluations of AI-assisted surgical navigation in urological oncology. Published in 2025 and already accumulating citations within its first year, this work signals significant early impact in a rapidly evolving field. By rigorously testing whether augmented reality overlays powered by artificial intelligence can meaningfully improve surgical precision and patient outcomes compared to established cognitive approaches, Manfredi is helping to define the evidence base for next-generation operating room technologies. His research positions him as an important voice in the ongoing transformation of robotic urology toward truly data-driven, image-guided surgical care.
Research Focus
Key Achievements
Top Papers
- 1